144 related articles for article (PubMed ID: 3238644)
1. Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension.
Miller KW; Keith JC
Thromb Haemost; 1988 Dec; 60(3):365-71. PubMed ID: 3238644
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte morphologic features and serum chemistry studies in ovine pregnancy-induced hypertension treated with thromboxane synthetase inhibitors.
Miller KW; Keith JC
Am J Obstet Gynecol; 1988 Nov; 159(5):1241-6. PubMed ID: 3189458
[TBL] [Abstract][Full Text] [Related]
3. Effects of the calcium antagonist nifedipine on thromboxane B2 level and platelet aggregation in hypertensive patients.
Uehara S; Handa H; Hirayama A
Arzneimittelforschung; 1986 Nov; 36(11):1687-9. PubMed ID: 3814228
[TBL] [Abstract][Full Text] [Related]
4. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
5. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
6. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
[TBL] [Abstract][Full Text] [Related]
7. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
[TBL] [Abstract][Full Text] [Related]
8. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.
Best LC; Holland TK; Jones PB; Russell RG
Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171
[TBL] [Abstract][Full Text] [Related]
9. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
Freeman MB; Sicard GA; Valentin LI; Neuberger S; Mangino MJ; Anderson CB
J Vasc Surg; 1988 Apr; 7(4):554-61. PubMed ID: 3127601
[TBL] [Abstract][Full Text] [Related]
10. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
Schumacher WA; Lucchesi BR
J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
[TBL] [Abstract][Full Text] [Related]
11. Platelet function in experimentally induced pancreatitis in the dog.
Jacobs RM; Murtaugh RJ; Fertel RH
Thromb Haemost; 1986 Apr; 55(2):197-200. PubMed ID: 3087002
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of U-63,557A, a thromboxane synthetase inhibitor, in an ovine model of pregnancy-induced hypertension.
Keith JC; Thatcher CD; Schaub RG
Am J Obstet Gynecol; 1987 Jul; 157(1):199-203. PubMed ID: 3605254
[TBL] [Abstract][Full Text] [Related]
13. Activation of platelets by microfibrils and collagen. A comparative study.
Legrand YJ; Fauvel F; Arbeille B; Leger D; Mouhli H; Gutman N; Muh JP
Lab Invest; 1986 May; 54(5):566-73. PubMed ID: 2939291
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
Menys VC; Davies JA
Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
[TBL] [Abstract][Full Text] [Related]
15. The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia.
Bar J; Zosmer A; Hod M; Elder MG; Sullivan MH
Thromb Haemost; 1997 Oct; 78(4):1255-61. PubMed ID: 9364994
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors.
Tubaro E; Belogi L; Mezzadri CM
Arzneimittelforschung; 1996 Jan; 46(1):35-41. PubMed ID: 8821515
[TBL] [Abstract][Full Text] [Related]
17. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity.
Park WH; Kim KS; Kim KH; Kim DS; Kim CH
Int Immunopharmacol; 2003 Jul; 3(7):971-8. PubMed ID: 12810354
[TBL] [Abstract][Full Text] [Related]
18. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
19. Effects of thromboxane synthetase inhibition on maternal-fetal homeostasis in gravid ewes with ovine pregnancy-induced hypertension.
Keith JC; Miller K; Eggleston MK; Kutruff J; Howerton T; Konczal C; McDaniels C
Am J Obstet Gynecol; 1989 Nov; 161(5):1305-13. PubMed ID: 2589456
[TBL] [Abstract][Full Text] [Related]
20. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation.
Zilla P; Fasol R; Groscurth P; Klepetko W; Reichenspurner H; Wolner E
J Thorac Cardiovasc Surg; 1989 Mar; 97(3):379-88. PubMed ID: 2918735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
